US 7709625
Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
granted A61KA61K48/00
Quick answer
US patent 7709625 (Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy) held by The Board of Regents of the University of Texas expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas
- Grant date
- Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K48/00